VCYT · Veracyte Inc. Common Stock
View on chartInsiders & Stakes
| Marc Stapley Chief Executive Officer | ▼ Sell | Tax Withholding | 432,073 Shares held | 9/2/2026 | View profile |
| Rebecca Chambers Chief Financial Officer | ▼ Sell | Open Market | 166,025 Shares held | 9/4/2026 | View profile |
| Phillip G. Febbo Chief Scientific & Med Officer | ▼ Sell | Open Market | 133,048 Shares held | 9/4/2026 | View profile |
| Annie McGuire EVP, General Counsel | ▼ Sell | Open Market | 131,160 Shares held | 9/4/2026 | View profile |
| John Leite Global Chief Commercial Off | ▼ Sell | Open Market | 124,329 Shares held | 9/21/2026 | View profile |
| Nova Tina Susan Director | ▲ Buy | Grant | 76,988 Shares held | 3/3/2022 | View profile |
| Kennedy Giulia C Chief Scientific & Med Officer | ▼ Sell | Open Market | 65,970 Shares held | 12/6/2022 | View profile |
| Robert S. Epstein Director | ▲ Buy | Grant | 57,718 Shares held | 6/11/2026 | View profile |
| Eliav Barr Director | ▲ Buy | Grant | 56,461 Shares held | 6/11/2026 | View profile |
| Kevin Richard Haas Chief Technology Officer | ▲ Buy | Grant | 44,221 Shares held | 4/10/2026 | View profile |
| Jonathan Wygant VP, Chief Accounting Officer | ▼ Sell | Tax Withholding | 43,226 Shares held | 9/2/2026 | View profile |
| Muna Bhanji Director | ▼ Sell | Open Market | 42,718 Shares held | 9/1/2026 | View profile |
| Bonnie H. Anderson Executive Chairwoman | ▼ Sell | Tax Withholding | 41,377 Shares held | 6/2/2023 | View profile |
| JONES EVAN/ FA Director | ▲ Buy | Grant | 34,634 Shares held | 6/11/2026 | View profile |
| BISHOP JOHN L Director | ▼ Sell | Open Market | 33,125 Shares held | 7/18/2023 | View profile |
| David Brent Shafer Director | ▲ Buy | Grant | 31,100 Shares held | 6/11/2026 | View profile |
| Thomas F. Miller Director | ▲ Buy | Grant | 31,100 Shares held | 6/11/2026 | View profile |
| Jens Holstein Director | ▼ Sell | Open Market | 27,471 Shares held | 9/14/2026 | View profile |
| Karin Eastham Director | ▼ Sell | Open Market | 15,097 Shares held | 6/18/2026 | View profile |
| Kevin K. Gordon Director | ▼ Sell | Open Market | 8,720 Shares held | 6/8/2022 | View profile |
Transaction History
| John Leite | ▼ Sell | Open Market | 4,015 | $161K | 9/21/2026 |
| Jens Holstein | ▼ Sell | Open Market | 5,000 | $205K | 9/14/2026 |
| Phillip G. Febbo | ▼ Sell | Open Market | 10,405 | $446K | 9/4/2026 |
| Phillip G. Febbo | ▼ Sell | Open Market | 2,705 | $118K | 9/4/2026 |
| Rebecca Chambers | ▼ Sell | Open Market | 2,477 | $106K | 9/4/2026 |
| Rebecca Chambers | ▼ Sell | Open Market | 1,175 | $51K | 9/4/2026 |
| Annie McGuire | ▼ Sell | Open Market | 2,154 | $92K | 9/4/2026 |
| Annie McGuire | ▼ Sell | Open Market | 1,100 | $48K | 9/4/2026 |
| John Leite | ▼ Sell | Tax Withholding | 3,961 | $178K | 9/2/2026 |
| Phillip G. Febbo | ▼ Sell | Tax Withholding | 3,639 | $163K | 9/2/2026 |
| Rebecca Chambers | ▼ Sell | Tax Withholding | 3,603 | $162K | 9/2/2026 |
| Annie McGuire | ▼ Sell | Tax Withholding | 3,215 | $144K | 9/2/2026 |
| Marc Stapley | ▼ Sell | Tax Withholding | 8,782 | $394K | 9/2/2026 |
| Jonathan Wygant | ▼ Sell | Tax Withholding | 1,361 | $61K | 9/2/2026 |
| Muna Bhanji | ▼ Sell | Open Market | 1,864 | $80K | 9/1/2026 |
| Karin Eastham | ▼ Sell | Open Market | 3,200 | $169K | 6/18/2026 |
| Karin Eastham | ▼ Sell | Open Market | 529 | $28K | 6/18/2026 |
| Karin Eastham | ▲ Buy | Grant | 5,272 | $0 | 6/11/2026 |
| JONES EVAN/ FA | ▲ Buy | Grant | 5,272 | $0 | 6/11/2026 |
| David Brent Shafer | ▲ Buy | Grant | 5,272 | $0 | 6/11/2026 |
| Eliav Barr | ▲ Buy | Grant | 5,272 | $0 | 6/11/2026 |
| Jens Holstein | ▲ Buy | Grant | 5,272 | $0 | 6/11/2026 |
| Muna Bhanji | ▲ Buy | Grant | 5,272 | $0 | 6/11/2026 |
| Thomas F. Miller | ▲ Buy | Grant | 5,272 | $0 | 6/11/2026 |
| Robert S. Epstein | ▲ Buy | Grant | 5,272 | $0 | 6/11/2026 |
| Marc Stapley | ▲ Buy | Option Exercise | 138,051 | $5.1M | 6/4/2026 |
| John Leite | ▼ Sell | Open Market | 13,975 | $700K | 6/4/2026 |
| Annie McGuire | ▼ Sell | Open Market | 1,400 | $69K | 6/4/2026 |
| Annie McGuire | ▼ Sell | Open Market | 1,776 | $89K | 6/4/2026 |
| Rebecca Chambers | ▼ Sell | Open Market | 1,600 | $79K | 6/4/2026 |
| Rebecca Chambers | ▼ Sell | Open Market | 1,961 | $98K | 6/4/2026 |
| Marc Stapley | ▼ Sell | Open Market | 138,051 | $6.9M | 6/4/2026 |
| Marc Stapley | ▼ Sell | Tax Withholding | 9,012 | $431K | 6/2/2026 |
| John Leite | ▼ Sell | Tax Withholding | 4,059 | $194K | 6/2/2026 |
| Annie McGuire | ▼ Sell | Tax Withholding | 3,292 | $157K | 6/2/2026 |
| Jonathan Wygant | ▼ Sell | Tax Withholding | 1,361 | $65K | 6/2/2026 |
| Rebecca Chambers | ▼ Sell | Tax Withholding | 3,693 | $177K | 6/2/2026 |
| Phillip G. Febbo | ▼ Sell | Tax Withholding | 3,730 | $178K | 6/2/2026 |
| Jonathan Wygant | ▲ Buy | Option Exercise | 24,000 | $595K | 5/22/2026 |
| Jonathan Wygant | ▼ Sell | Open Market | 24,000 | $1.1M | 5/22/2026 |
| Robert S. Epstein | ▼ Sell | Open Market | 10,000 | $440K | 5/20/2026 |
| Annie McGuire | ▼ Sell | Open Market | 5,102 | $194K | 5/6/2026 |
| Annie McGuire | ▼ Sell | Open Market | 5,102 | $204K | 5/6/2026 |
| Kevin Richard Haas | ▲ Buy | Grant | 44,221 | $0 | 4/10/2026 |
| Jonathan Wygant | ▲ Buy | Grant | 10,525 | $0 | 3/6/2026 |
| Annie McGuire | ▲ Buy | Grant | 32,892 | $0 | 3/6/2026 |
| Annie McGuire | ▲ Buy | Grant | 26,314 | $0 | 3/6/2026 |
| Phillip G. Febbo | ▲ Buy | Grant | 29,603 | $0 | 3/6/2026 |
| Phillip G. Febbo | ▲ Buy | Grant | 6,578 | $0 | 3/6/2026 |
| John Leite | ▲ Buy | Grant | 36,181 | $0 | 3/6/2026 |
| John Leite | ▲ Buy | Grant | 6,578 | $0 | 3/6/2026 |
| Marc Stapley | ▲ Buy | Grant | 92,099 | $0 | 3/6/2026 |
| Rebecca Chambers | ▲ Buy | Grant | 36,181 | $0 | 3/6/2026 |
| Rebecca Chambers | ▲ Buy | Grant | 13,157 | $0 | 3/6/2026 |
| Annie McGuire | ▼ Sell | Open Market | 4,994 | $176K | 3/4/2026 |
| Annie McGuire | ▼ Sell | Open Market | 1,664 | $60K | 3/4/2026 |
| Rebecca Chambers | ▼ Sell | Open Market | 4,400 | $156K | 3/4/2026 |
| Rebecca Chambers | ▼ Sell | Open Market | 13,941 | $506K | 3/4/2026 |
| Marc Stapley | ▼ Sell | Open Market | 19,244 | $684K | 3/4/2026 |
| Marc Stapley | ▼ Sell | Open Market | 26,279 | $953K | 3/4/2026 |
| John Leite | ▼ Sell | Open Market | 5,260 | $185K | 3/4/2026 |
| Rebecca Chambers | ▼ Sell | Tax Withholding | 7,234 | $260K | 3/2/2026 |
| Annie McGuire | ▼ Sell | Tax Withholding | 6,902 | $249K | 3/2/2026 |
| John Leite | ▼ Sell | Tax Withholding | 7,517 | $271K | 3/2/2026 |
| Jonathan Wygant | ▼ Sell | Tax Withholding | 3,006 | $108K | 3/2/2026 |
| Phillip G. Febbo | ▼ Sell | Tax Withholding | 6,035 | $217K | 3/2/2026 |
| Phillip G. Febbo | ▼ Sell | Open Market | 13,425 | $485K | 3/2/2026 |
| Marc Stapley | ▼ Sell | Tax Withholding | 19,455 | $701K | 3/2/2026 |
| John Leite | ▲ Buy | Grant | 47,149 | $0 | 2/26/2026 |
| John Leite | ▼ Sell | Tax Withholding | 8,905 | $345K | 2/26/2026 |
| Marc Stapley | ▲ Buy | Grant | 139,074 | $0 | 2/26/2026 |
| Marc Stapley | ▼ Sell | Tax Withholding | 35,841 | $1.4M | 2/26/2026 |
| Rebecca Chambers | ▲ Buy | Grant | 59,324 | $0 | 2/26/2026 |
| Rebecca Chambers | ▼ Sell | Tax Withholding | 12,049 | $467K | 2/26/2026 |
| Phillip G. Febbo | ▲ Buy | Grant | 71,806 | $0 | 2/26/2026 |
| Phillip G. Febbo | ▼ Sell | Tax Withholding | 24,486 | $949K | 2/26/2026 |
| Annie McGuire | ▲ Buy | Grant | 50,999 | $0 | 2/26/2026 |
| Annie McGuire | ▼ Sell | Tax Withholding | 10,867 | $421K | 2/26/2026 |
| Annie McGuire | ▼ Sell | Open Market | 100 | $4K | 12/16/2025 |
| Annie McGuire | ▼ Sell | Open Market | 10,639 | $459K | 12/16/2025 |
| Karin Eastham | ▲ Buy | Option Exercise | 10,000 | $76K | 12/5/2025 |
| Karin Eastham | ▼ Sell | Open Market | 800 | $37K | 12/5/2025 |
| Karin Eastham | ▲ Buy | Option Exercise | 10,000 | $79K | 12/5/2025 |
| Karin Eastham | ▼ Sell | Open Market | 6,392 | $285K | 12/5/2025 |
| Karin Eastham | ▼ Sell | Open Market | 12,808 | $587K | 12/5/2025 |
| Annie McGuire | ▼ Sell | Open Market | 720 | $34K | 12/4/2025 |
| Annie McGuire | ▼ Sell | Open Market | 702 | $33K | 12/4/2025 |
| Rebecca Chambers | ▼ Sell | Open Market | 8,537 | $398K | 12/4/2025 |
| Marc Stapley | ▼ Sell | Open Market | 4,448 | $209K | 12/4/2025 |
| Rebecca Chambers | ▼ Sell | Open Market | 4,741 | $224K | 12/4/2025 |
| Marc Stapley | ▼ Sell | Open Market | 3,220 | $152K | 12/4/2025 |
| John Leite | ▼ Sell | Open Market | 1,278 | $61K | 12/4/2025 |
| Phillip G. Febbo | ▼ Sell | Tax Withholding | 2,955 | $136K | 12/2/2025 |
| Annie McGuire | ▼ Sell | Tax Withholding | 3,052 | $141K | 12/2/2025 |
| Rebecca Chambers | ▼ Sell | Tax Withholding | 3,384 | $156K | 12/2/2025 |
| Marc Stapley | ▼ Sell | Tax Withholding | 7,914 | $365K | 12/2/2025 |
| John Leite | ▼ Sell | Tax Withholding | 2,900 | $134K | 12/2/2025 |
| Jonathan Wygant | ▼ Sell | Tax Withholding | 1,325 | $61K | 12/2/2025 |
| John Leite | ▼ Sell | Open Market | 2,808 | $140K | 11/25/2025 |
| JONES EVAN/ FA | ▼ Sell | Open Market | 1,106 | $56K | 11/25/2025 |
| Jens Holstein | ▼ Sell | Open Market | 1,491 | $61K | 11/20/2025 |
| Jens Holstein | ▼ Sell | Open Market | 7,049 | $299K | 11/20/2025 |
| Jens Holstein | ▼ Sell | Open Market | 1,460 | $63K | 11/20/2025 |
| Jonathan Wygant | ▼ Sell | Open Market | 5,102 | $216K | 11/10/2025 |
| Jonathan Wygant | ▼ Sell | Open Market | 5,818 | $234K | 11/7/2025 |
| JONES EVAN/ FA | ▲ Buy | Option Exercise | 10,000 | $79K | 11/5/2025 |
| JONES EVAN/ FA | ▼ Sell | Open Market | 5,872 | $265K | 11/5/2025 |
| JONES EVAN/ FA | ▼ Sell | Open Market | 24,296 | $1.1M | 11/5/2025 |
| JONES EVAN/ FA | ▼ Sell | Open Market | 657 | $30K | 11/5/2025 |
| Karin Eastham | ▼ Sell | Open Market | 9,674 | $387K | 11/5/2025 |
| JONES EVAN/ FA | ▼ Sell | Open Market | 10,837 | $475K | 11/5/2025 |
| JONES EVAN/ FA | ▲ Buy | Option Exercise | 10,000 | $76K | 11/5/2025 |
| JONES EVAN/ FA | ▼ Sell | Open Market | 408 | $17K | 11/5/2025 |
| Rebecca Chambers | ▼ Sell | Open Market | 7,000 | $287K | 11/5/2025 |
| JONES EVAN/ FA | ▼ Sell | Open Market | 1,126 | $48K | 11/5/2025 |
| Annie McGuire | ▼ Sell | Open Market | 6,466 | $259K | 11/5/2025 |
| JONES EVAN/ FA | ▲ Buy | Option Exercise | 10,000 | $53K | 11/5/2025 |
| Jonathan Wygant | ▲ Buy | Grant | 2,886 | $0 | 10/28/2025 |
| Phillip G. Febbo | ▼ Sell | Open Market | 8,349 | $301K | 10/6/2025 |
| Robert S. Epstein | ▲ Buy | Option Exercise | 10,000 | $79K | 10/1/2025 |
| Robert S. Epstein | ▼ Sell | Open Market | 21,473 | $753K | 10/1/2025 |
| John Leite | ▼ Sell | Open Market | 2,539 | $89K | 10/1/2025 |
| Annie McGuire | ▼ Sell | Open Market | 2,160 | $76K | 10/1/2025 |
| Annie McGuire | ▼ Sell | Open Market | 2,283 | $77K | 9/19/2025 |
| Marc Stapley | ▼ Sell | Open Market | 7,667 | $233K | 9/4/2025 |
| Marc Stapley | ▼ Sell | Tax Withholding | 7,914 | $238K | 9/2/2025 |
| Phillip G. Febbo | ▼ Sell | Tax Withholding | 2,955 | $89K | 9/2/2025 |
| Jonathan Wygant | ▼ Sell | Tax Withholding | 1,648 | $50K | 9/2/2025 |
| John Leite | ▼ Sell | Tax Withholding | 2,902 | $87K | 9/2/2025 |
| Rebecca Chambers | ▼ Sell | Tax Withholding | 5,371 | $162K | 9/2/2025 |
| Annie McGuire | ▼ Sell | Tax Withholding | 3,507 | $106K | 9/2/2025 |
| Robert S. Epstein | ▲ Buy | Grant | 9,321 | $0 | 6/18/2025 |
| Eliav Barr | ▲ Buy | Grant | 9,321 | $0 | 6/18/2025 |
| Jens Holstein | ▲ Buy | Grant | 9,321 | $0 | 6/18/2025 |
| JONES EVAN/ FA | ▲ Buy | Grant | 9,321 | $0 | 6/18/2025 |
| Muna Bhanji | ▲ Buy | Grant | 9,321 | $0 | 6/18/2025 |
| Thomas F. Miller | ▲ Buy | Grant | 9,321 | $0 | 6/18/2025 |
| Karin Eastham | ▲ Buy | Grant | 9,321 | $0 | 6/18/2025 |
| David Brent Shafer | ▲ Buy | Grant | 9,321 | $0 | 6/18/2025 |
| Karin Eastham | ▼ Sell | Open Market | 4,590 | $122K | 6/13/2025 |
| Muna Bhanji | ▼ Sell | Open Market | 4,589 | $122K | 6/13/2025 |
| John Leite | ▼ Sell | Open Market | 2,809 | $76K | 6/4/2025 |
| Annie McGuire | ▼ Sell | Tax Withholding | 3,505 | $94K | 6/2/2025 |
| Rebecca Chambers | ▼ Sell | Tax Withholding | 5,370 | $144K | 6/2/2025 |
| John Leite | ▼ Sell | Tax Withholding | 2,900 | $78K | 6/2/2025 |
| Jonathan Wygant | ▼ Sell | Tax Withholding | 1,848 | $49K | 6/2/2025 |
| Phillip G. Febbo | ▼ Sell | Tax Withholding | 2,955 | $79K | 6/2/2025 |
| Marc Stapley | ▼ Sell | Tax Withholding | 9,399 | $251K | 6/2/2025 |
| John Leite | ▼ Sell | Open Market | 2,400 | $74K | 3/7/2025 |
| John Leite | ▼ Sell | Open Market | 5,011 | $160K | 3/7/2025 |
| Rebecca Chambers | ▲ Buy | Grant | 30,200 | $0 | 3/6/2025 |
| Phillip G. Febbo | ▲ Buy | Grant | 24,160 | $0 | 3/6/2025 |
| Jonathan Wygant | ▲ Buy | Grant | 13,288 | $0 | 3/6/2025 |
| John Leite | ▲ Buy | Grant | 36,240 | $0 | 3/6/2025 |
| Annie McGuire | ▲ Buy | Grant | 30,200 | $0 | 3/6/2025 |
| Marc Stapley | ▲ Buy | Grant | 90,601 | $0 | 3/6/2025 |
| Marc Stapley | ▼ Sell | Open Market | 23,414 | $794K | 3/4/2025 |
| Marc Stapley | ▼ Sell | Open Market | 1,094 | $38K | 3/4/2025 |
| Annie McGuire | ▼ Sell | Open Market | 1,142 | $38K | 3/4/2025 |
| Marc Stapley | ▼ Sell | Open Market | 28,189 | $925K | 3/4/2025 |
| Phillip G. Febbo | ▼ Sell | Open Market | 4,467 | $147K | 3/4/2025 |
| Phillip G. Febbo | ▼ Sell | Open Market | 3,570 | $121K | 3/4/2025 |
| Marc Stapley | ▼ Sell | Tax Withholding | 20,324 | $706K | 3/2/2025 |
| Jonathan Wygant | ▼ Sell | Tax Withholding | 4,301 | $150K | 3/2/2025 |
| Phillip G. Febbo | ▼ Sell | Tax Withholding | 6,754 | $235K | 3/2/2025 |
| Rebecca Chambers | ▼ Sell | Tax Withholding | 11,070 | $385K | 3/2/2025 |
| John Leite | ▼ Sell | Tax Withholding | 7,650 | $266K | 3/2/2025 |
| Annie McGuire | ▼ Sell | Tax Withholding | 8,255 | $287K | 3/2/2025 |
| Marc Stapley | ▼ Sell | Tax Withholding | 34,273 | $1.2M | 2/27/2025 |
| Marc Stapley | ▲ Buy | Grant | 67,277 | $0 | 2/27/2025 |
| John Leite | ▼ Sell | Open Market | 5,746 | $194K | 2/27/2025 |
| Phillip G. Febbo | ▼ Sell | Tax Withholding | 15,672 | $530K | 2/27/2025 |
| John Leite | ▲ Buy | Grant | 11,006 | $0 | 2/27/2025 |
| Rebecca Chambers | ▲ Buy | Grant | 23,170 | $0 | 2/27/2025 |
| Phillip G. Febbo | ▲ Buy | Grant | 30,589 | $0 | 2/27/2025 |
| Annie McGuire | ▲ Buy | Grant | 13,466 | $0 | 2/27/2025 |
| Annie McGuire | ▼ Sell | Tax Withholding | 7,000 | $237K | 2/27/2025 |
| Rebecca Chambers | ▼ Sell | Tax Withholding | 11,911 | $403K | 2/27/2025 |
| Rebecca Chambers | ▼ Sell | Open Market | 527 | $23K | 2/3/2025 |
| Robert S. Epstein | ▲ Buy | Option Exercise | 20,000 | $161K | 1/6/2025 |
| Karin Eastham | ▲ Buy | Option Exercise | 10,000 | $53K | 1/2/2025 |
| Karin Eastham | ▼ Sell | Open Market | 5,309 | $213K | 1/2/2025 |
| Karin Eastham | ▼ Sell | Open Market | 4,691 | $190K | 1/2/2025 |
| Marc Stapley | ▼ Sell | Open Market | 5,190 | $225K | 12/13/2024 |
| Marc Stapley | ▼ Sell | Open Market | 400 | $18K | 12/13/2024 |
| Annie McGuire | ▼ Sell | Open Market | 18,699 | $823K | 12/4/2024 |
| Phillip G. Febbo | ▼ Sell | Open Market | 3,934 | $173K | 12/4/2024 |
| Jonathan Wygant | ▼ Sell | Open Market | 956 | $41K | 12/3/2024 |
| John Leite | ▼ Sell | Open Market | 1,050 | $45K | 12/3/2024 |
| Rebecca Chambers | ▼ Sell | Open Market | 7,000 | $303K | 12/3/2024 |
| Annie McGuire | ▼ Sell | Tax Withholding | 1,918 | $85K | 12/2/2024 |
| John Leite | ▼ Sell | Tax Withholding | 1,314 | $58K | 12/2/2024 |
| Jonathan Wygant | ▼ Sell | Tax Withholding | 1,087 | $48K | 12/2/2024 |
| Marc Stapley | ▼ Sell | Tax Withholding | 5,748 | $254K | 12/2/2024 |
| Rebecca Chambers | ▼ Sell | Tax Withholding | 3,464 | $153K | 12/2/2024 |
| Phillip G. Febbo | ▼ Sell | Tax Withholding | 6,738 | $297K | 12/2/2024 |
| Jonathan Wygant | ▼ Sell | Open Market | 5,032 | $216K | 11/27/2024 |
| Karin Eastham | ▼ Sell | Open Market | 1,600 | $59K | 11/19/2024 |
| Karin Eastham | ▼ Sell | Open Market | 10,125 | $392K | 11/19/2024 |
| Karin Eastham | ▼ Sell | Open Market | 3,006 | $114K | 11/19/2024 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Veracyte (VCYT) Stock Seen as Undervalued After 107% Rise
Recent coverage notes that Veracyte’s shares have risen more than 100% while still appearing inexpensive relative to its earnings multiple. The company’s trailing P/E of about 30.6 and an analyst consensus target near $58 suggest the market may be pricing in further upside. The stock is currently trading near the lower end of its 52‑week range, close to a support level that has been tested multiple times.
Veracyte (VCYT) Stock Seen as Undervalued After 107% Rise. Recent coverage notes that Veracyte’s shares have risen more than 100% while still appearing inexpensive relative to its earnings multiple. The company’s trailing P/E of about 30.6 and an analyst consensus target near $58 suggest the market may be pricing in further upside. The stock is currently trading near the lower end of its 52‑week range, close to a support level that has been tested multiple times.